Machine Learning Histology Segmentation for Dopaminergic Cell Loss

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing dopaminergic neural cell loss in regions of the brain, such as substantia nigra reticulata (SNR) and substantia nigra compacta dorsal (SNCD), are time-consuming and prone to human bias, hindering the development of effective therapies for Parkinson's disease due to the lack of automated systems for accurate segmentation and quantification.

Innovation Solution

A machine learning pipeline is developed to identify and quantify dopaminergic neural cells by segmenting regions of SNR and SNCD in histology images using a trained model, employing encoder-decoder architectures and transfer learning to enhance accuracy and reduce latency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If manual annotation and drawing regions of interest by neuropathologists is used, then measurement precision of dopaminergic neural cell loss is improved, but loss of time in the study process increases

Engineering Contradiction:
Improvedopaminergic neural cell loss analysisVSAvoidstudy duration
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces the mechanical manual annotation process performed by neuropathologists with an automated machine learning system. The system uses trained models to automatically identify, segment, and quantify dopaminergic neural cells in histology images, eliminating the need for manual drawing of regions of interest while maintaining measurement precision through algorithmic consistency and objectivity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The machine learning system performs self-service by automatically completing the entire analysis pipeline without human intervention. The trained models independently identify regions of interest, segment neural cells, and generate quantification results, allowing the system to serve its own analytical needs without requiring neuropathologist time for manual annotation.

Inventive Principle:
Principle #25Self-service

2Measurement precision

If manual counting of dopaminergic neural cells by trained pathologists is used, then measurement precision is improved, but productivity decreases

Engineering Contradiction:
Improvedopaminergic neural cell quantificationVSAvoidanalysis throughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent substitutes the manual counting process with an automated image analysis system. The machine learning models process histology images and automatically count dopaminergic neural cells within segmented regions, replacing the time-consuming manual enumeration by pathologists while maintaining precise quantification through systematic image processing.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system performs excessive action by automatically analyzing all cells in the field of view rather than relying on selective manual counting. This ensures complete enumeration of dopaminergic neural cells without the sampling limitations of manual methods, thereby increasing productivity while maintaining or improving measurement precision.

Inventive Principle:
Principle #16Partial or excessive action

3Productivity

If automated machine learning models are developed to identify regions of SNR and SNCD, then productivity increases, but device complexity increases

Engineering Contradiction:
Improveautomated analysis speedVSAvoidmachine learning pipeline complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent segments the complex analysis task into distinct modular components: a region identification model that locates substantia nigra regions (SNR and SNCD), and a cell segmentation model that identifies individual dopaminergic neural cells. This segmentation of functionality reduces overall system complexity by allowing each component to be developed, trained, and optimized independently while maintaining high productivity through automated processing.

Inventive Principle:
Principle #1Segmentation

4Measurement precision

If deep learning models are used for image segmentation, then measurement precision is improved, but device complexity increases

Engineering Contradiction:
Improveneural cell segmentation accuracyVSAvoidmodel architecture complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent employs deep learning models that automatically learn complex segmentation patterns from training data, replacing the need for manual definition of segmentation criteria. The models achieve high measurement precision by automatically adapting to variations in cell morphology and staining patterns, with the complexity managed through automated training procedures rather than manual configuration.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS20250226102A1Techniques for determining dopaminergic neural cell loss using machine learning
Publication Date: 2025.07.10 GENENTECH INC
  • US20250226102A1 patent drawing
  • US20250226102A1 patent drawing
  • US20250226102A1 patent drawing

AI summary

Described herein are techniques for identifying regions of substantia nigra reticulata (SNR) and regions of substantia nigra compact dorsal (SNCD) in histology images and quantifying a number of dopaminergic neural cells within the images. In some embodiments, an image of a section of a brain may be input into a first machine learning model to obtain a first segmentation map comprising pixel-wise labels indicative of whether a corresponding pixel in the image depicts a region of SNR or SNCD. In some embodiments, the image (and, optionally, the first segmentation map) may also be input to a second machine learning model trained to generate a second segmentation map comprising pixel-wise labels indicating whether a corresponding pixel of the image depicts a dopaminergic neural cell or neural background tissue. The number of cells within the image may be determined based on the second segmentation map.